Cargando…

Editorial: Progresses in the Drug Treatment of Chronic Cardiopulmonary Diseases

Detalles Bibliográficos
Autores principales:	Li, Xiaohui, Kosanovic, Djuro, Wang, Xiao-Jian, Cao, Yunshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160424/ https://www.ncbi.nlm.nih.gov/pubmed/35662696 http://dx.doi.org/10.3389/fphar.2022.910212

Ejemplares similares

Editorial: Oxidative Stress in Cardiovascular Diseases and Pulmonary Hypertension
por: Parajuli, Nirmal, et al.
Publicado: (2022)

Editorial: The challenges of drug repurposing in diseases related to chronic inflammation
por: Collotta, Debora, et al.
Publicado: (2023)

Editorial: Multitasking Biomolecules in Human Pathologies: Known Players on Their Unexpected Journeys
por: Wygrecka, Malgorzata, et al.
Publicado: (2020)

Editorial: Advances in drug-induced diseases
por: Liu, Yao, et al.
Publicado: (2023)

Editorial: Drugging p53 for non-cancer diseases
por: Jiang, Fan, et al.
Publicado: (2022)

Editorial: Structure-Based Drug Design for Diagnosis and Treatment of Neurological Diseases
por: Ramsay, Rona R., et al.
Publicado: (2017)

Editorial: Anti-inflammatory immunopharmacology in the prevention and treatment of major chronic diseases
por: Zhang, Qiuwang, et al.
Publicado: (2023)

Natural plant products in treatment of pulmonary arterial hypertension
por: Xiang, Lili, et al.
Publicado: (2018)

Editorial: Chronic inflammation and pharmacological interventions in cardiovascular diseases
por: Wang, Xiaoping, et al.
Publicado: (2022)

Editorial: Biological drugs and biosimilars in autoimmune diseases
por: Wajda, Anna, et al.
Publicado: (2023)

Editorial: Drug re-purposing for the treatment of bacterial infections
por: Tomás, María, et al.
Publicado: (2022)

Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease
por: Petrillo, Francesco, et al.
Publicado: (2021)

Editorial: Traditional medicine and chronic inflammatory diseases
por: Liu, Wei, et al.
Publicado: (2023)

In situ Pulmonary Artery Thrombosis: A Previously Overlooked Disease
por: Cao, Yunshan, et al.
Publicado: (2021)

Editorial: Mechanisms and New Targets for the Treatment of Chronic Pain
por: Nieto, Francisco Rafael, et al.
Publicado: (2020)

Editorial: Novel therapeutic target and drug discovery for neurological diseases
por: Zhao, Kaiyue, et al.
Publicado: (2022)

Editorial: Nanomedicine in Infectious Diseases: Drug Delivery and Vaccines
por: Marepally, Srujan, et al.
Publicado: (2022)

Editorial: Phosphodiesterases as Drug Targets in Airway and Inflammatory Diseases
por: Mokry, Juraj, et al.
Publicado: (2021)

Editorial: Drug-drug interactions in pharmacology
por: Pichini, Simona, et al.
Publicado: (2023)

Progress in the Application of Drugs for the Treatment of Multiple Sclerosis
por: Wei, Weipeng, et al.
Publicado: (2021)

Editorial: The role of mushrooms and their nutraceuticals for chronic and degenerative diseases
por: Rai, Sachchida Nand, et al.
Publicado: (2022)

Editorial: Enteric inflammation and chronic diseases: Is there a link?
por: Marzocco, Stefania, et al.
Publicado: (2022)

Editorial: Chronic inflammation and pharmacological interventions in cardiovascular diseases, volume II
por: Yan, Aiwei, et al.
Publicado: (2023)

Editorial: Novel Therapeutic Target and Drug Development in Neurovascular Retinal Diseases
por: Shao, Zhuo, et al.
Publicado: (2021)

Editorial: Liver diseases and programmed cell death
por: Cao, Peng, et al.
Publicado: (2023)

Editorial: Natural compounds regulating epigenetics for treating chronic inflammatory diseases
por: Zhang, Mingyu, et al.
Publicado: (2023)

Editorial: Drug Development and Target Discovery in Pulmonary Vascular Diseases
por: Zhang, Rui, et al.
Publicado: (2020)

Editorial: Biomarkers in Drug Hypersensitivity
por: Agúndez, José A. G., et al.
Publicado: (2017)

Editorial: Advances in Drug Formulation
por: Mukherjee, Biswajit, et al.
Publicado: (2020)

Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease, Volume II
por: Bucolo, Claudio, et al.
Publicado: (2022)

Editorial: Applications of Herbal Medicine to Control Chronic Kidney Disease
por: Chen, Jianping, et al.
Publicado: (2021)

Editorial: Immunity in the development of anti-cancer drug resistance
por: Meng, Ya, et al.
Publicado: (2022)

Editorial: Natural product treatment of gastrointestinal diseases
por: Sun, Mingyu, et al.
Publicado: (2022)

Editorial: Translational Research and Drug Repurposing for Non-Communicable Diseases (NCDs)
por: Akindele, Abidemi J., et al.
Publicado: (2022)

Editorial: Ethnopharmacological Strategies for Drug Discovery Against African Neglected Diseases
por: Igoli, John O., et al.
Publicado: (2022)

Editorial: New opportunities in drug design for the management and treatment of type 2 diabetes
por: Rasouli, Hassan, et al.
Publicado: (2023)

Editorial: Drug-induced immunogenic cell death patterns and anti-cancer treatment
por: Xia, Xianghou, et al.
Publicado: (2023)

Advances in the Progression and Prognosis Biomarkers of Chronic Kidney Disease
por: Yan, Zhonghong, et al.
Publicado: (2021)

Impact of extracellular vesicles on the pathogenesis, diagnosis, and potential therapy in cardiopulmonary disease
por: Soto-Vázquez, Yixel M., et al.
Publicado: (2023)

Research Progress on PARP14 as a Drug Target
por: Qin, Wei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_oh0i0lr28ft1gdtp9ag4ko1qfq